HER2-positive breast cancers have two subcategories: HER2-enriched (ER and PR-negative but HER2-positive) and luminal HER2 (ER and PR-positive and HER2-positive) (Kneubil et al. 2013; Vici et al. 2015). This evidence concerns the gene ERBB2 and breast carcinoma.